Home
SCIO Path to Approval
Early Clinical Research
Strategy and TPP
Translational Medicine and Epigenetics
Biologics, Cell and Gene Therapy
Real World Evidence
Repurposing
Orphan Drug Solutions
Biomarkers and Surrogate Endpoints
Regulatory Affairs FDA and EMA
Medical Affairs and Clinical Research
Due Diligence
Trial Management & Trial Rescue
People
Senior Advisors
Candida Fratazzi
Claudio Carini
Federico Goodsaid
Our Team
Our Clients
Our Collaborators
Testimonials
Resources
BBCR Voice
Case Studies
Published Studies
Conferences & Presentations
Job Opportunities
Contact Info
Select Page
`
Tagged: Clinical Trials. Boston biotech
The Strategic Clinical Innovation Organization method, developed by BBCR, can help streamline the clinical trial process by operating on the fundamental principle that strategy and design are keys for the success of drug and medical device development.
March 29th, 2022 | Clinical Trials. Boston biotech
Understanding Personalized Medicine
June 26th, 2019 | Clinical Trials. Boston biotech
Patient-Centricity: Empower and inform patients making them partners in the research process
June 5th, 2019 | Clinical Trials. Boston biotech
Search for:
Categories
Biomarkers & Surrogate Endpoints
Company News
Drug Development
Due Diligence
Early Clinical Development
Industry News
Medical Affairs and Clinical Research
Miscellaneous
Orphan Diseases
Pre-IND
Precision Medicine
Rare Disease
Real World Evidence
Regulatory
Regulatory Affairs
Strategy and TPP
Translation Medicine and Epigenetics
Trial Management
Trial Rescue
Recent Posts
A pioneering figure in the area of rare diseases and orphan drug early-stage clinical research and regulatory strategies, Dr. Candida Fratazzi has an impressive 25-year track record in this specialized field.
BBCR is committed to cultivating and enhancing a product’s unique strengths at every stage, from initial conception to successful market launch. With deep expertise in cell therapy, biologics, and gene therapy—particularly in the realm of rare diseases—we provide strategic guidance and innovative solutions that form the foundation of our consultancy practice.
BBCR embraces innovative strategic consulting for highly effective clinical development planning and regulatory strategy. Reach out today to learn more about how we can help advance your project.
Partnering with BBCR Consulting streamlines the clinical trial process by delivering tailored clinical and regulatory roadmaps. Our approach focuses on simplified programs and optimized protocols, designed to align seamlessly with each client’s unique requirements.
BBCR meets clients’ needs in the fast paced and ever-changing regulatory environment. As specialists in Orphan and Personalized Medicine, BBCR helps clients identify areas of need or economic interest and helps them to find homes for treatments for rare diseases and precision medicine.